All Pharma News
Rutherrin Shows Complete Lung Cancer Response Preclinically

Rutherrin Shows Complete Lung Cancer Response Preclinically
ACCESSWIRE
19 Jun 2024
Share Share
Rutherrin® Increases Efficacy Of Immunotherapy Preclinically

Rutherrin® Increases Efficacy Of Immunotherapy Preclinically
ACCESSWIRE
18 Jun 2024
Share Share
Theralase Reminds Of Annual General Special Meeting

Theralase Reminds Of Annual General Special Meeting
ACCESSWIRE
14 Jun 2024
Share Share
Theralase(R) Successfully Destroys Lung Cancer

Theralase(R) Successfully Destroys Lung Cancer
ACCESSWIRE
06 Jun 2024
Share Share
Theralase(R) Technology Effective in Virus Inactivation

Theralase(R) Technology Effective in Virus Inactivation
ACCESSWIRE
04 Jun 2024
Share Share
Theralase(R) Release`s 1Q2024 Financial Statements

Theralase(R) Release`s 1Q2024 Financial Statements
ACCESSWIRE
30 May 2024
Share Share
Theralase(R) Expands Clinical Team

Theralase(R) Expands Clinical Team
ACCESSWIRE
02 May 2024
Share Share
Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement
ACCESSWIRE
24 Apr 2024
Share Share
Theralase(R) Granted Canadian Cancer Vaccine Patent

Theralase(R) Granted Canadian Cancer Vaccine Patent
ACCESSWIRE
05 Apr 2024
Share Share
Theralase(R) Release`s 4Q2023 Interim Financial Statements

Theralase(R) Release`s 4Q2023 Interim Financial Statements
ACCESSWIRE
27 Mar 2024
Share Share